Advertisement

Use of Vasopressor Drugs in Cardiac Arrest

  • Anette C. Krismer
  • Norman A. Paradis
  • Volker Wenzel
  • John Southall
Part of the Contemporary Cardiology book series (CONCARD)

Abstract

The importance of vital organ perfusion in patients suffering cardiac arrest (CA) makes arterial vasomotor tone, and the resultant perfusion pressure, critical in resuscitation from sudden death. After failure of countershock, ventilation, and oxygenation, the target organ for resuscitative pharmacotherapy becomes the arterial vascular smooth muscle cell. Selective stimulation of various vascular smooth muscle cell surface receptors is accomplished through administration of exogenous agents with the intention of altering blood flow away from nonvital organ beds toward the myocardium and brain.

Keywords

Cardiac Arrest Myocardial Blood Flow Cardiopulmonary Resuscitation Arginine Vasopressin Spontaneous Circulation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Standards for cardiopulmonary resuscitation (CPR) and emergency cardiac care (ECC). 3. Advanced life support. JAMA 1974; 227(Suppl):852–860.Google Scholar
  2. 2.
    Gottlieb R. Ueber die Wirkung der Nebennierenextrakt auf Herz und Blutdruck. Arch f Exp Path u Pharm Leipzig 1896; 38:99–112.Google Scholar
  3. 3.
    Beck C, Rand HI. Cardiac arrest during anaesthesia and surgery. JAMA 1949; 141:1230–1233.Google Scholar
  4. 4.
    Bodon C. The intracardiac injection of epinephrine. Lancet 1923; 1:586.Google Scholar
  5. 5.
    Gerbode F. The cardiac emergency. Ann.Surg. 1952; 135:431.PubMedGoogle Scholar
  6. 6.
    McCarthy KC. The problem of cardiac arrest. JAMA 1958; 168:2101–2103.Google Scholar
  7. 7.
    Wortsman J, Frank S, Cryer PE. Adrenomedullary response to maximal stress in humans. Am J Med 1984; 77:779–784.PubMedGoogle Scholar
  8. 8.
    Redding JS, Haynes RR, Thomas JD. Drug therapy in resuscitation from electromechanical dissociation. Crit Care Med 1983; 11:681–684.PubMedGoogle Scholar
  9. 9.
    Berridge MJ. Phosphatidylinositol hydrolysis and calcium signaling. Adv Cyclic Nucleotide Res 1981; 14:289–299.PubMedGoogle Scholar
  10. 10.
    Exton JH. Mechanisms involved in alpha-adrenergic phenomena: role of calcium ions in actions of catecholamines in liver and other tissues. Am J Physiol 1980; 238:E3–E12.PubMedGoogle Scholar
  11. 11.
    Gierschig P, Jakops, K,H,. Mechanism for inhibition of adenylate cyclase by alpha-2 adrenergic receptors. In: The alpha-2 adrenergic receptors. Limberd LE, ed. New York: Clifton, 1988, pp. 75–113.Google Scholar
  12. 12.
    Ahlquist. A study of the adrenotropic receptors. Am J Physiol 1948; 153:586–600.Google Scholar
  13. 13.
    Lindner KH, Ahnefeld FW, Bowdler IM. Comparison of different doses of epinephrine on myocardial perfusion and resuscitation success during cardiopulmonary resuscitation in a pig model. Am J Emerg Med 1991; 9:27–31.PubMedGoogle Scholar
  14. 14.
    Ditchey RV, Winkler JV, Rhodes CA. Relative lack of coronary blood flow during closed-chest resuscitation in dogs. Circulation 1982; 66:297–302.PubMedGoogle Scholar
  15. 15.
    Michael JR, Guerci AD, Koehler RC, et al. Mechanisms by which epinephrine augments cerebral and myocardial perfusion during cardiopulmonary resuscitation in dogs. Circulation 1984; 69:822–835.PubMedGoogle Scholar
  16. 16.
    Niemann JT, Rosborough JP, Ung S, Criley JM. Coronary perfusion pressure during experimental cardiopulmonary resuscitation. Ann Emerg Med 1982; 11:127–131.PubMedGoogle Scholar
  17. 17.
    Paradis NA, Martin GB, Rivers EP, et al. Coronary perfusion pressure and the return of spontaneous circulation in human cardiopulmonary resuscitation. JAMA 1990; 263:1106–1113.PubMedGoogle Scholar
  18. 18.
    Redding JS, Pearson JW. Resuscitation from ventricular fibrillation. Drug therapy. JAMA 1968; 203: 255–260.PubMedGoogle Scholar
  19. 19.
    Pearson JW, Redding, J.S. Influence of peripheral vascular tone on cardiac resuscitation. Anesth Analg 1967; 46:746–752.Google Scholar
  20. 20.
    Otto CW, Yakaitis RW, Blitt CD. Mechanism of action of epinephrine in resuscitation from asphyxial arrest. Crit Care Med 1981; 9:321–324.PubMedGoogle Scholar
  21. 21.
    Yakaitis RW, Otto CW, Blitt CD. Relative importance of alpha and beta adrenergic receptors during resuscitation. Crit Care Med 1979; 7:293–296.PubMedGoogle Scholar
  22. 22.
    Ditchey RV, Slinker BK. Phenylephrine plus propranolol improves the balance between myocardial oxygen supply and demand during experimental cardiopulmonary resuscitation. Am Heart J 1994; 127: 324–30.PubMedGoogle Scholar
  23. 23.
    Crile GW, Dolley DH. An experimental research into the resuscitation of dogs killed by anaestheitics and asphyxia. J Exp Med 1906; 8:713–724.Google Scholar
  24. 24.
    Pearson JW, Redding, J.S. The role of epinephrine in cardiac resuscitation. Anesth Analg 1963; 42: 599–606.PubMedGoogle Scholar
  25. 25.
    Pearson JW, Redding JS. Peripheral vascular tone on cardiac resuscitation. Anesth Analg 1965; 44: 746–752.PubMedGoogle Scholar
  26. 26.
    Redding JS. Evaluation of drugs for cardiac resuscitation. Anesth 1963; 24:203–207.Google Scholar
  27. 27.
    Brillman J, Sanders A, Otto CW, et al. Comparison of epinephrine and phenylephrine for resuscitation and neurologic outcome of cardiac arrest in dogs. Ann Emerg Med 1987; 16:11–17.PubMedGoogle Scholar
  28. 28.
    Arnold A. Sympathomimetic amine-induced responses of effectors organs subserved by alpha, beta-1,and beta-2 adrenoreceptors. In: Adrenergic Activators and Inhibitors. Handbook of Experimental Pharmacology. Vol. 54/I. Szkekeres, ed. Heidelberg: Springer-Verlag, 1980.Google Scholar
  29. 29.
    Trendelenberg U, Weiner, N. Catecholamines. Handbook of Experimental Pharmacology. Vol. 90/1. Heidelberg: Springer-Verlag, 1988.Google Scholar
  30. 30.
    Lindner KH, Dirks B, Strohmenger HU, et al. Randomised comparison of epinephrine and vasopressin in patients with out-of-hospital ventricular fibrillation. Lancet 1997; 349: 535–537.PubMedGoogle Scholar
  31. 31.
    Starke K, Endo T, Taube HD. Relative pre-and postsynaptic potencies of alpha-adrenoceptor agonists in the rabbit pulmonary artery. Naunyn Schmiedebergs Arch Pharmacol 1975; 291:55–78.PubMedGoogle Scholar
  32. 32.
    Szkekeres. Adrenergic activators and inhibitors. Handbook of Experimental Pharmacology. Vol. 54/I. Heidelberg: Springer-Verlag, 1980.Google Scholar
  33. 33.
    Weiner N. Norepinephrine, epinephrine and the sympathomimetic amines. In: Goodman and Gilman’s: The Pharmacological Basis of Therapeutics. Gilman AG, Goodman, L.S., eds. New York: MacMillan, 1980, pp. 138–175.Google Scholar
  34. 34.
    Woodhouse SP, Case, C., Cox, S. High and standard dose of adrenaline do not alter survival compared with placebo in cardiac arrest. Resusciation 1995; 30:243–290.Google Scholar
  35. 35.
    Guyatt GH, Sackett DL, Cook DJ. Users’ guides to the medical literature. II. How to use an article about therapy or prevention. B. What were the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group. JAMA 1994; 271:59–63.PubMedGoogle Scholar
  36. 36.
    Parker EA, Boomer RJ, Bell SC. Parenteral incompatibilities—past, present and future. Bull Parenter Drug Assoc 1967; 21:197–207.PubMedGoogle Scholar
  37. 37.
    Bonhomme L, Benhamou D, Comoy E, Preaux N. Stability of epinephrine in alkalinized solutions. Ann Emerg Med 1990; 19:1242–1244.PubMedGoogle Scholar
  38. 38.
    Yakaitis RW, Ewy GA, Otto CW, et al. Influence of time and therapy on ventricular defibrillation in dogs. Crit Care Med 1980; 8:157–163.PubMedGoogle Scholar
  39. 39.
    Niemann JT, Cairns CB, Sharma J, Lewis RJ. Treatment of prolonged ventricular fibrillation. Immediate countershock versus high-dose epinephrine and CPR preceding countershock. Circulation 1992; 85:281–287.PubMedGoogle Scholar
  40. 40.
    DeBehnke DJ, Angelos MG, Leasure JE. Use of cardiopulmonary bypass, high-dose epinephrine, and standard-dose epinephrine in resuscitation from post-countershock electromechanical dissociation. Ann Emerg Med 1992; 21: 1051–1057.PubMedGoogle Scholar
  41. 41.
    Koide T, Wieloch TW, Siesjo BK. Circulating catecholamines modulate ischemic brain damage. J Cereb Blood Flow Metab 1986; 6:559–565.PubMedGoogle Scholar
  42. 42.
    Gervais HW, Schleien CL, Koehler RC, et al. Effect of adrenergic drugs on cerebral blood flow, metabolism, and evoked potentials after delayed cardiopulmonary resuscitation in dogs. Stroke 1991; 22:1554–1561.PubMedGoogle Scholar
  43. 43.
    Freedman BJ. Accidential adrenaline overdoosage and its treatment with piperoxan. Lancet 1955; 2: 575–578.Google Scholar
  44. 44.
    Hall AH, Kulig KW, Rumack BH. Intravenous epinephrine abuse. Am J Emerg Med 1987; 5:64,65.PubMedGoogle Scholar
  45. 45.
    Levine RD, Orkin LR. Epinephrine overdose; a continuing problem. N Y State J Med 1981; 81: 1669,1670.PubMedGoogle Scholar
  46. 46.
    Novey HS, Meleyco LN. Alarming reaction after intravenous administration of 30 mLof epinephrine. Jama 1969; 207:2435,2436.PubMedGoogle Scholar
  47. 47.
    Brown CG, Taylor RB, Werman HA, et al. Myocardial oxygen delivery/consumption during cardiopulmonary resuscitation: a comparison of epinephrine and phenylephrine. Ann Emerg Med 1988; 17: 302–308.PubMedGoogle Scholar
  48. 48.
    Lindner KH, Ahnefeld FW, Pfenninger EG, et al. Effects of epinephrine and norepinephrine on cerebral oxygen delivery and consumption during open-chest CPR. Ann Emerg Med 1990; 19:249–254.PubMedGoogle Scholar
  49. 49.
    Ditchey RV, Lindenfeld J. Failure of epinephrine to improve the balance between myocardial oxygen supply and demand during closed-chest resuscitation in dogs. Circulation 1988; 78:382–389.PubMedGoogle Scholar
  50. 50.
    Livesay JJ, Follette DM, Fey KH, et al. Optimizing myocardial supply/demand balance with alpha-adrenergic drugs during cardiopulmonary resuscitation. J Thorac Cardiovasc Surg 1978; 76:244–251.PubMedGoogle Scholar
  51. 51.
    Brown CG, Katz SE, Werman HA, et al. The effect of epinephrine versus methoxamine on regional myocardial blood flow and defibrillation rates following a prolonged cardiorespiratory arrest in a swine model. Am J Emerg Med 1987; 5:362–369.PubMedGoogle Scholar
  52. 52.
    Paradis NA, Brown CG. High-dose adrenaline and cardiac arrest. Lancet 1988; 2:749.PubMedGoogle Scholar
  53. 53.
    Chappel CI. RG, Bazales T. et al. Comparison of cardiotoxic action of certain sympathomimetic amines. Can J Biochem Physiol 1959; 37:35–42.PubMedGoogle Scholar
  54. 54.
    Todd GL, Baroldi G, Pieper GM, et al. Experimental catecholamine-induced myocardial necrosis. II. Temporal development of isoproterenol-induced contraction band lesions correlated with ECG, hemodynamic and biochemical changes. J Mol Cell Cardiol 1985; 17:647–656.PubMedGoogle Scholar
  55. 55.
    Tang W, Weil MH, Sun S, et al. Epinephrine increases the severity of postresuscitation myocardial dysfunction. Circulation 1995; 92:3089–3093.PubMedGoogle Scholar
  56. 56.
    Haft JI. Cardiovascular injury induced by sympathetic catecholamines. Prog Cardiovasc Dis 1974; 17: 73–86.PubMedGoogle Scholar
  57. 57.
    Waters LL, deSuto-Nagy, G.I. Lesions of the coronary arteries and great vessels of the dog following injection of adrenalin. Their prevention with dibenamine. Science 1950; 111:634–635.PubMedGoogle Scholar
  58. 58.
    Tang W, Weil MH, Gazmuri RJ, et al. Pulmonary ventilation/perfusion defects induced by epinephrine during cardiopulmonary resuscitation. Circulation 1991; 84:2101–2107.PubMedGoogle Scholar
  59. 59.
    Tang W, C. Epinephrine produces both hypoxemia and hypercarbia during CPR. Crit Care Med 1990; 18: 276.Google Scholar
  60. 60.
    Berg RA, Otto CW, Kern KB, et al. High-dose epinephrine results in greater early mortality after resuscitation from prolonged cardiac arrest in pigs: a prospective, randomized study. Crit Care Med 1994; 22:282–290.PubMedGoogle Scholar
  61. 61.
    Baroldi G, Silver MD, Lixfeld W, McGregor DC. Irreversible myocardial damage resembling catecholamine necrosis secondary to acute coronary occlusion in dogs: its prevention by propranolol. J Mol Cell Cardiol 1977; 9: 687–691.PubMedGoogle Scholar
  62. 62.
    Opie LH, Thandroyen FT, Muller C, Bricknell OL. Adrenaline-induced “oxygen-wastage” and enzyme release from working rat heart. Effects of calcium antagonism, beta-blockade, nicotinic acid and coronary artery ligation. J Mol Cell Cardiol 1979; 11:1073–1094.PubMedGoogle Scholar
  63. 63.
    Redding JS, Pearson JW. Metabolic acidosis: a factor in cardiac resuscitation. South Med J 1967; 60: 926–932.PubMedGoogle Scholar
  64. 64.
    Jude JR, Neumaster T, Kfoury E. Vasopressor-cardiotonic drugs in cardiac resuscitation. Acta Anaesthesiol Scand Suppl 1968; 29:147–163.PubMedGoogle Scholar
  65. 65.
    Holmes HR, Babbs CF, Voorhees WD, et al. Influence of adrenergic drugs upon vital organ perfusion during CPR. Crit Care Med 1980; 8:137–140.PubMedGoogle Scholar
  66. 66.
    Ralston SH, Tacker WA, Showen L, et al. Endotracheal versus intravenous epinephrine during electromechanical dissociation with CPR in dogs. Ann Emerg Med 1985; 14:1044–1048.PubMedGoogle Scholar
  67. 67.
    Brown CG, Werman HA, Davis EA, et al. Comparative effect of graded doses of epinephrine on regional brain blood flow during CPR in a swine model. Ann Emerg Med 1986; 15:1138–1144.PubMedGoogle Scholar
  68. 68.
    Brown CG, Werman HA, Davis EA, et al. The effects of graded doses of epinephrine on regional myocardial blood flow during cardiopulmonary resuscitation in swine. Circulation 1987; 75:491–497.PubMedGoogle Scholar
  69. 69.
    Lindner KH, Ahnefeld FW, Bowdler IM. The effect of epinephrine on hemodynamics, acid-base status and potassium during spontaneous circulation and cardiopulmonary resuscitation. Resuscitation 1988; 16:251–261.PubMedGoogle Scholar
  70. 70.
    Lindner KH, Ahnefeld FW, Bowdler IM. Comparison of epinephrine and dopamine during cardiopulmonary resuscitation. Intensive Care Med 1989; 15:432–438.PubMedGoogle Scholar
  71. 71.
    Lindner KH, Ahnefeld FW, Bowdler IM, Prengel AW. Influence of epinephrine on systemic, myocardial, and cerebral acid-base status during cardiopulmonary resuscitation. Anesthesiology 1991; 74:333–339.PubMedGoogle Scholar
  72. 72.
    Lindner KH, Strohmenger HU, Prengel AW, et al. Hemodynamic and metabolic effects of epinephrine during cardiopulmonary resuscitation in a pig model. Crit Care Med 1992; 20:1020–1026.PubMedGoogle Scholar
  73. 73.
    Dean JM, Koehler RC, Schleien CL, et al. Improved blood flow during prolonged cardiopulmonary resuscitation with 30% duty cycle in infant pigs. Circulation 1991; 84:896–904.PubMedGoogle Scholar
  74. 74.
    Gonzalez ER, Ornato JP, Garnett AR, et al. Dose-dependent vasopressor response to epinephrine during CPR in human beings. Ann Emerg Med 1989; 18:920–926.PubMedGoogle Scholar
  75. 75.
    Paradis NA, Martin GB, Rosenberg J, et al. The effect of standard-and high-dose epinephrine on coronary perfusion pressure during prolonged cardiopulmonary resuscitation. Jama 1991; 265:1139–1144.PubMedGoogle Scholar
  76. 76.
    Brown CG, Martin DR, Pepe PE, et al. A comparison of standard-dose and high-dose epinephrine in cardiac arrest outside the hospital. The Multicenter High-Dose Epinephrine Study Group. N Engl J Med 1992; 327: 1051–1055.PubMedGoogle Scholar
  77. 77.
    Callaham M, Madsen CD, Barton CW, et al. A randomized clinical trial of high-dose epinephrine and norepinephrine vs standard-dose epinephrine in prehospital cardiac arrest. Jama 1992; 268:2667–2672.PubMedGoogle Scholar
  78. 78.
    Abramson NS, Safar, P., and Sutton-Tyrrell, K. A randomized clinical trial of escalating doses of high dose epinephrine during cardiac resucitation. Critical care medicine 1995; 23:A178 (abstract).Google Scholar
  79. 79.
    Vandycke C, Martens P. High dose versus standard dose epinephrine in cardiac arrest-a meta-analysis. Resuscitation 2000; 45:161–166.PubMedGoogle Scholar
  80. 80.
    Joyce SM, Barsan WG, Doan LA. Use of phenylephrine in resuscitation from asphyxial arrest. Ann Emerg Med 1983; 12:418–421.PubMedGoogle Scholar
  81. 81.
    Brown CG, Birinyi F, Werman HA, et al. The comparative effects of epinephrine versus phenylephrine on regional cerebral blood flow during cardiopulmonary resuscitation. Resuscitation 1986; 14:171–183.PubMedGoogle Scholar
  82. 82.
    Brown CG, Werman HA, Davis EA, et al. The effect of high-dose phenylephrine versus epinephrine on regional cerebral blood flow during CPR. Ann Emerg Med 1987; 16:743–748.PubMedGoogle Scholar
  83. 83.
    Berkowitz ID, Gervais H, Schleien CL, et al. Epinephrine dosage effects on cerebral and myocardial blood flow in an infant swine model of cardiopulmonary resuscitation. Anesthesiology 1991; 75:1041–1050.PubMedGoogle Scholar
  84. 84.
    Schleien CL, Koehler RC, Gervais H, et al. Organ blood flow and somatosensory-evoked potentials during and after cardiopulmonary resuscitation with epinephrine or phenylephrine. Circulation 1989; 79:1332–1342.PubMedGoogle Scholar
  85. 85.
    Brillman JA, Sanders AB, Otto CW, et al. Outcome of resuscitation from fibrillatory arrest using epinephrine and phenylephrine in dogs. Crit Care Med 1985; 13:912,913.PubMedGoogle Scholar
  86. 86.
    Ditchey RV, Rubio-Perez A, Slinker BK. Beta-adrenergic blockade reduces myocardial injury during experimental cardiopulmonary resuscitation. J Am Coll Cardiol 1994; 24:804–812.PubMedGoogle Scholar
  87. 87.
    Silfvast T, Saarnivaara L, Kinnunen A, et al. Comparison of adrenaline and phenylephrine in out-of-hospital cardiopulmonary resuscitation. A double-blind study. Acta Anaesthesiol Scand 1985; 29: 610–613.PubMedGoogle Scholar
  88. 88.
    Standards and guidelines for cardiopulmonary resuscitation (CPR) and emergency cardiac care (ECC). JAMA 1986; 255:2841–3044.Google Scholar
  89. 89.
    Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care. International consensus on science. Resuscitation 2000; 46:1–477 (Generic).Google Scholar
  90. 90.
    Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care. Part 6: advanced cardiovascular life support: 7C: a guide to the international ACLS algorithms. The American Heart Association in collaboration with the international liaison committee on resuscitation. Circulation 2000; 102: I142–I157.Google Scholar
  91. 91.
    Thrasher TN, Keil LC. Systolic pressure predicts plasma vasopressin responses to hemorrhage and vena caval constriction in dogs. Am J Physiol Regul Integr Comp Physiol 2000; 279:R1035–R1042.PubMedGoogle Scholar
  92. 91a.
    Schmittinger CA, Wenzel V, Stadlbauer KH, et al. Drug therapy during CPR. Anasthesiol Intensivmed Notfallmed Schmerzther 2003; 38:651–672.PubMedGoogle Scholar
  93. 92.
    Hays RM. Agents affecting the renal conservation of water. In: Goodman and Gilman’s: The Pharmacological Basis of Therapeutics. Goodman G, Rall, Murad, ed. New York: Macmilian, 1985, pp. 908–919.Google Scholar
  94. 93.
    Birnbaumer M. Vasopressin receptors. Trends Endocrinol Metab 2000; 11:406–410.PubMedGoogle Scholar
  95. 94.
    Fox AW, May RE, Mitch WE. Comparison of peptide and nonpeptide receptor-mediated responses in rat tail artery. J Cardiovasc Pharmacol 1992; 20:282–289.PubMedGoogle Scholar
  96. 95.
    Garcia-Villalon AL, Garcia JL, Fernandez N, et al. Regional differences in the arterial response to vasopressin: role of endothelial nitric oxide. Br J Pharmacol 1996; 118:1848–1854.PubMedGoogle Scholar
  97. 96.
    Moursi MM, van Wylen DG, D’Alecy LG. Regional blood flow changes in response to mildly pressor doses of triglycyl desamino lysine and arginine vasopressin in the conscious dog. J Pharmacol Exp Ther 1985; 232: 360–368.PubMedGoogle Scholar
  98. 97.
    Wallace AW, Tunin CM, Shoukas AA. Effects of vasopressin on pulmonary and systemic vascular mechanics. Am J Physiol 1989; 257(Pt 2):H1228–H1234.PubMedGoogle Scholar
  99. 98.
    Okamura T, Ayajiki K, Fujioka H, Toda N. Mechanisms underlying arginine vasopressin-induced relaxation in monkey isolated coronary arteries. J Hypertens 1999; 17:673–678.PubMedGoogle Scholar
  100. 99.
    Suzuki Y, Satoh S, Oyama H, et al. Vasopressin mediated vasodilation of cerebral arteries. J Auton Nerv Syst 1994; 49(Suppl):S129–S132.PubMedGoogle Scholar
  101. 100.
    Russ RD, Walker BR. Role of nitric oxide in vasopressinergic pulmonary vasodilatation. Am J Physiol 1992; 262(Pt 2):H743–H747.PubMedGoogle Scholar
  102. 101.
    Xu YJ, Gopalakrishnan V. Vasopressin increases cytosolic free [Ca2+] in the neonatal rat cardiomyocyte. Evidence for V1 subtype receptors. Circ Res 1991; 69:239–245.PubMedGoogle Scholar
  103. 102.
    Fujisawa S, Iijima T. On the inotropic actions of arginine vasopressin in ventricular muscle of the guinea pig heart. Jpn J Pharmacol 1999; 81:309–312.PubMedGoogle Scholar
  104. 103.
    Lindner KH, Prengel AW, Pfenninger EG, et al. Vasopressin improves vital organ blood flow during closed-chest cardiopulmonary resuscitation in pigs. Circulation 1995; 91:215–221.PubMedGoogle Scholar
  105. 104.
    Prengel AW, Lindner KH, Keller A. Cerebral oxygenation during cardiopulmonary resuscitation with epinephrine and vasopressin in pigs. Stroke 1996; 27:1241–1248.PubMedGoogle Scholar
  106. 105.
    Wenzel V, Lindner KH, Prengel AW, et al. Vasopressin improves vital organ blood flow after prolonged cardiac arrest with postcountershock pulseless electrical activity in pigs. Crit Care Med 1999; 27:486–492.PubMedGoogle Scholar
  107. 106.
    Wenzel V, Linder KH, Augenstein S, et al. Vasopressin combined with epinephrine decreases cerebral perfusion compared with vasopressin alone during cardiopulmonary resuscitation in pigs. Stroke 1998; 29:1462–1467; discussion 1467,1468.PubMedGoogle Scholar
  108. 107.
    Paradis NA, Koscove EM. Epinephrine in cardiac arrest: a critical review. Ann Emerg Med 1990; 19: 1288–1301.PubMedGoogle Scholar
  109. 108.
    Lolait SJ, O’Carroll AM, Brownstein MJ. Molecular biology of vasopressin receptors. Ann N Y Acad Sci 1995; 771:273–292.PubMedGoogle Scholar
  110. 109.
    Lindemann R. Endotracheal administration of epinephrine during cardiopulmonary resuscitation. Am J Dis Child 1982; 136:753,754.PubMedGoogle Scholar
  111. 110.
    Wenzel V, Lindner KH, Prengel AW, et al. Endobronchial vasopressin improves survival during cardiopulmonary resuscitation in pigs. Anesthesiology 1997; 86:1375–1381.PubMedGoogle Scholar
  112. 111.
    Kruse JA, Vyskocil JJ, Haupt MT. Intraosseous infusions: a flexible option for the adult or child with delayed, difficult, or impossible conventional vascular access. Crit Care Med 1994; 22:728,729.PubMedGoogle Scholar
  113. 112.
    Voelckel WG, Lindner KH, Wenzel V, et al. Intraosseous blood gases during hypothermia: correlation with arterial, mixed venous, and sagittal sinus blood. Crit Care Med 2000; 28:2915–2920.PubMedGoogle Scholar
  114. 113.
    Anonymous. Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 2000; 102(Suppl):I1–I384.Google Scholar
  115. 114.
    Anonymous. Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care. Resuscitation 2000; 46:1–447.Google Scholar
  116. 115.
    Wenzel V, Lindner KH, Krismer AC, et al. Repeated administration of vasopressin but not epinephrine maintains coronary perfusion pressure after early and late administration during prolonged cardiopulmonary resuscitation in pigs. Circulation 1999; 99:1379–1384.PubMedGoogle Scholar
  117. 116.
    Prengel AW, Lindner KH, Keller A, Lurie KG. Cardiovascular function during the postresuscitation phase after cardiac arrest in pigs: a comparison of epinephrine versus vasopressin. Crit Care Med 1996; 24: 2014–2019.PubMedGoogle Scholar
  118. 117.
    Lindner KH, Brinkmann A, Pfenninger EG, et al. Effect of vasopressin on hemodynamic variables, organ blood flow, and acid-base status in a pig model of cardiopulmonary resuscitation. Anesth Analg 1993; 77: 427–435.PubMedGoogle Scholar
  119. 118.
    Luce JM, Rizk NA, Niskanen RA. Regional blood flow during cardiopulmonary resuscitation in dogs. Crit Care Med 1984; 12:874–878.PubMedGoogle Scholar
  120. 119.
    Strohmenger HU, Lindner KH, Wienen W, Vogt J. Effects of the AT1-selective angiotensin II antagonist, telmisartan, on hemodynamics and ventricular function after cardiopulmonary resuscitation in pigs. Resuscitation 1997; 35:61–68.PubMedGoogle Scholar
  121. 120.
    Prengel AW, Lindner KH, Wenzel V, et al. Splanchnic and renal blood flow after cardiopulmonary resuscitation with epinephrine and vasopressin in pigs. Resuscitation 1998; 38:19–24.PubMedGoogle Scholar
  122. 121.
    Voelckel WG, Lindner KH, Wenzel V, et al. Effects of vasopressin and epinephrine on splanchnic blood flow and renal function during and after cardiopulmonary resuscitation in pigs. Crit Care Med 2000; 28:1083–1088.PubMedGoogle Scholar
  123. 122.
    Voelckel WG, Lindner KH, Wenzel V, et al. Effect of small-dose dopamine on mesenteric blood flow and renal function in a pig model of cardiopulmonary resuscitation with vasopressin. Anesth Analg 1999; 89: 1430–1436.PubMedGoogle Scholar
  124. 123.
    Wenzel V, Lindner KH, Krismer AC, et al. Survival with full neurologic recovery and no cerebral pathology after prolonged cardiopulmonary resuscitation with vasopressin in pigs. J Am Coll Cardiol 2000; 35:527–533.PubMedGoogle Scholar
  125. 124.
    Gazmuri RJ, Maldonado FA. Postresuscitation management. In: Weil MH, Tang W, eds. CPR—Resuscitation of the arrested heart. Philadelphia, PA: Saunders, 1999, pp. 179–191.Google Scholar
  126. 125.
    Kampfl A, Schmutzhard E, Franz G, et al. Prediction of recovery from post-traumatic vegetative state with cerebral magnetic-resonance imaging. Lancet 1998; 351:1763–1767.PubMedGoogle Scholar
  127. 126.
    Landry DW, Levin HR, Gallant EM, et al. Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med 1997; 25:1279–1282.PubMedGoogle Scholar
  128. 127.
    Argenziano M, Choudhri AF, Oz MC, et al. A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement. Circulation 1997; 96(Suppl): II-286–II-290.Google Scholar
  129. 128.
    Argenziano M, Chen JM, Choudhri AF, et al. Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent. J Thorac Cardiovasc Surg 1998; 116: 973–980.PubMedGoogle Scholar
  130. 129.
    Mets B, Michler RE, Delphin ED, et al. Refractory vasodilation after cardiopulmonary bypass for heart transplantation in recipients on combined amiodarone and angiotensin-converting enzyme inhibitor therapy: a role for vasopressin administration. J Cardiothorac Vasc Anesth 1998; 12:326–329.PubMedGoogle Scholar
  131. 130.
    Gold JA, Cullinane S, Chen J, et al. Vasopressin as an alternative to norepinephrine in the treatment of milrinone-induced hypotension. Crit Care Med 2000; 28:249–52.PubMedGoogle Scholar
  132. 131.
    Lindner KH, Haak T, Keller A, et al. Release of endogenous vasopressors during and after cardiopulmonary resuscitation. Heart 1996; 75:145–150.PubMedGoogle Scholar
  133. 132.
    Lindner KH, Prengel AW, Brinkmann A, et al. Vasopressin administration in refractory cardiac arrest. Ann Intern Med 1996; 124:1061–1064.PubMedGoogle Scholar
  134. 133.
    Stiell IG, Hebert PC, Wells GA, et al. Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Lancet 2001; 358(9276):105–109.PubMedGoogle Scholar
  135. 134.
    Morris DC, Dereczyk BE, Grzybowski M, et al. Vasopressin can increase coronary perfusion pressure during human cardiopulmonary resuscitation. Acad Emerg Med 1997; 4:878–883.PubMedGoogle Scholar
  136. 135.
    Wenzel V, Lindner KH, Baubin MA, Voelckel WG. Vasopressin decreases endogenous catecholamine plasma concentrations during cardiopulmonary resuscitation in pigs. Crit Care Med 2000; 28:1096–1100.PubMedGoogle Scholar
  137. 136.
    Mayr VD, Wenzel V, Voelckel WG, et al. Developing a vasopressor combination in a pig model of adult asphyxial cardiac arrest. Circulation 2001; 104:1651–1656.PubMedGoogle Scholar
  138. 137.
    Wenzel V, Lindner KH, Mayer H, et al. Vasopressin combined with nitroglycerin increases endocardial perfusion during cardiopulmonary resuscitation in pigs. Resuscitation 1998; 38:13–17.PubMedGoogle Scholar
  139. 138.
    Lurie KG, Voelckel WG, Iskos DN, et al. Combination drug therapy with vasopressin, adrenaline (epinephrine) and nitroglycerin improves vital organ blood flow in a porcine model of ventricular fibrillation. Resuscitation 2002; 54:187–94.PubMedGoogle Scholar
  140. 139.
    Wenzel V, Ewy GA, Lindner KH. Vasopressin and endothelin during cardiopulmonary resuscitation. Crit Care Med 2000; 28(Suppl):N233–N235.PubMedGoogle Scholar
  141. 140.
    Krismer AC, Hogan QH, Wenzel V, et al. The efficacy of epinephrine or vasopressin for resuscitation during epidural anesthesia. Anesth Analg 2001; 93:734–742.PubMedGoogle Scholar
  142. 141.
    Krismer AC, Lindner KH, Kornberger R, et al. Cardiopulmonary resuscitation during severe hypothermia in pigs: does epinephrine or vasopressin increase coronary perfusion pressure? Anesth Analg 2000; 90:69–73.PubMedGoogle Scholar
  143. 142.
    Kornberger E, Lindner KH, Mayr VD, et al. Effects of epinephrine in a pig model of hypothermic cardiac arrest and closed-chest cardiopulmonary resuscitation combined with active rewarming. Resuscitation 2001; 50: 301–308.PubMedGoogle Scholar
  144. 143.
    Voelckel WG, Lurie KG, Lindner KH, et al. Vasopressin improves survival after cardiac arrest in hypovolemic shock. Anesth Analg 2000; 91:627–634.PubMedGoogle Scholar
  145. 144.
    Stadlbauer KH, Wagner-Berger HG, Raedler C, et al. Vasopressin, but not fluid resuscitation ensured survival in a liver trauma model with uncontrolled hemorrhagic shock in pigs. Anesthesiology 2002; 38:693–704.Google Scholar
  146. 145.
    Voelckel WG, Lurie KG, McKnite S, et al. Comparison of epinephrine and vasopressin in a pediatric porcine model of asphyxial cardiac arrest. Crit Care Med 2000; 28:3777–3783.PubMedGoogle Scholar
  147. 146.
    Wenzel V, Lindner KH. Employing vasopressin during cardiopulmonary resuscitation and vasodilatory shock as a lifesaving vasopressor. Cardiovasc Res 2001; 51:529–541.PubMedGoogle Scholar
  148. 147.
    Wenzel V, Krismer AC, Arntz HR, et al. A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation. N Engl J Med 2004; 350:105–113.PubMedGoogle Scholar

Copyright information

© Humana Press Inc., Totowa, NJ 2005

Authors and Affiliations

  • Anette C. Krismer
    • 1
  • Norman A. Paradis
    • 2
    • 3
    • 4
  • Volker Wenzel
    • 1
  • John Southall
    • 5
  1. 1.Department of Anesthesiology and Critical Care MedicineLeopold-Franzens-UniversityInnsbruckAustria
  2. 2.Department of Emergency MedicineUniversity of Colorado Health Sciences CenterDenver
  3. 3.Department of SurgeryUniversity of Colorado Health Sciences CenterDenver
  4. 4.Department of MedicineUniversity of Colorado Health Sciences CenterDenver
  5. 5.Department of Emergency MedicineMaine Medical CenterPortland

Personalised recommendations